Discovery Therapeutics, Inc.
Small Business (1-10M TTM Revenue)
Discovery Therapeutics, Inc., headquartered in Richmond, Virginia, USA, is a privately held, clinical-stage biopharmaceutical company focused on discovery, development, and commercialization of receptor subtype-selective compounds for the treatment of cardio-renal diseases. Discovery Therapeutics, Inc.’s product pipeline includes adenosine agonists and antagonists for the diagnosis and treatment of cardiovascular disease and FLAP antagonists for the treatment of chronic kidney disease.
|Discovery Therapeutics, Inc. 2028 Dabney Road Richmond, VA, 23230 United States
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.